Patients in our cohort tended to have obesity-related comorbidities, which were long-standing, with a tendency to be on a greater number of medications, were more likely to use CPAP or BiPAP to control OSA, and were more likely to be on insulin for T2DM control. This evidence concerns the gene INS and type 2 diabetes mellitus.